文献速递乳腺MR

基于多参数MRI的影像组学列线图预测HER2阳性乳腺癌激素受体状态

Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
PubMed 文献 · Clin Radiol · 2023-09-28

本研究纳入HER2阳性浸润性乳腺癌患者,随机分为训练集68例和验证集30例,从T2WI、ADC和DCE图像提取影像组学特征并构建列线图。联合三序列的影像组学标签诊断效能优于任一单序列(训练集AUC 0.797,验证集AUC 0.75);

要点

  • 联合T2WI、ADC和DCE三序列的影像组学标签诊断效能优于任一单序列。
  • 瘤周水肿是识别HER2阳性乳腺癌激素受体状态的独立预测因子。

核心结论

  • 基于多参数MRI的列线图整合影像组学标签和瘤周水肿,可评估HER2阳性乳腺癌的激素受体状态,并提高诊断准确性。

研究设计与样本

  • 回顾性研究,HER2阳性浸润性乳腺癌患者随机分为训练集68例和验证集30例,以组织病理学激素受体状态为参考标准,从T2WI、ADC和DCE图像分别提取1096个特征。

关键影像表现/征象

  • 在T2WI、ADC和DCE图像上勾画三维容积感兴趣区(VOI)提取影像组学特征。
  • 瘤周水肿被多因素logistic回归分析确定为识别激素受体状态的独立预测因子。

诊断标准与关键数值

  • 联合T2WI、ADC和DCE三序列的影像组学标签诊断效能优于任一单序列,训练集AUC 0.797、验证集AUC 0.75。
  • 经特征降维后从合并的T2WI、ADC和DCE图像中获得10个影像组学特征。

临床应用与阅片要点

  • 阅片时可关注HER2阳性乳腺癌的瘤周水肿征象,并将其与多参数MRI影像组学标签联合用于评估激素受体状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the value of multiparametric magnetic resonance imaging (MRI)-based radiomics nomograms for predicting the hormone receptor (HR) status of HER2-positive breast cancer.

MATERIALS AND METHODS: Patients with HER2-positive invasive breast cancer were divided randomly into training (68 patients) and validation (30 patients) sets. All were classified as either HR-positive (HR+) or negative (HR-) at histopathology. Two radiologists outlined the three-dimensional (3D) volumetric regions of interest (VOI) on the MRI images. Features (n=1,096) were extracted from the T2-weighted imaging (WI), apparent diffusion coefficient (ADC), and dynamic contrast-enhanced (DCE) images separately. Dimensionality was reduced using feature screening. Binary radiomics prediction models were established using a logistic regression classifier and were validated in the validation set. To construct a nomogram, independent predictors were identified using multivariate logistic regression analysis. The predictive efficacy of the model was assessed using the area under the receiver operating characteristic curve (AUC).

RESULTS: Ten radiomics features were obtained after feature dimensionality reduction based on the merged T2WI, ADC, and DCE images. The diagnostic efficacy of the radiomics signature using the three sequences was better than that of any single sequence (training set AUC: 0.797; validation set AUC: 0.75). Using multivariate logistic regression analysis, the independent predictors for identifying HR status were combined radiomics signature and peritumoural oedema. Nomograms constructed by combining the radiomics signature and peritumoural oedema showed good discrimination in both the training and validation sets (AUC: 0.815 and 0. 805, respectively).

CONCLUSION: A multiparametric MRI-based nomogram incorporating the radiomics signature and peritumoural oedema can assess the HR status of HER2-positive breast cancer. The resulting model can improve diagnostic accuracy, improving patient outcomes.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Sang L, Liu Z, Huang C, et al. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer. Clin Radiol. 2023. PMID: 37838543. doi:10.1016/j.crad.2023.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。